The Necker-Enfants Malades Institute is administered by one Director assisted by the two department Heads and one General secretary in charge the administration. Each PI or CoPI is responsible for his (her) scientific project and for the use of his (her) allocated space
Twenty one research teams are founding members of the Necker-Enfants Malades Institute. The teams are grouped in two departments: a department of Cell biology (Growth and Signalling) and a department of, Immunology, Infectiology and Haematology (I2H). The Necker-Enfants Malades Institute currently comprises 103 senior scientists, one third of whom are medical doctors, 60 technicians and engineers, 35 postdoctoral fellows and 37 PhD students.
«Cell biology (Growth and Signalling)» Department
Prolactin and Growth Hormone Pathophysiology: Translational Approaches
Claude-Agnès REYNAUD : ERC B-RESPONSE : Memory and innate-like B-cell subsets: deciphering a multi-layered B-cell response in mice and humans
Pamela SCHNUPF : ERC NICHEADAPT - Deciphering the niche adaptations of a gut commensal involved in educating the host immune system
Former ERC grantees
Jean-François BACH : ERC HYGIENE - The hygiene hypothesis: revisiting the concept by integrating epidemiology and mechanistic studies
Mario PENDE : ERC RariTOR - mTOR pathophysiology in rare human diseases
Jean-Claude WEILL : ERC Advanced - MEMO-B : The B cell memory program: cell fate determinants and functional diversity of B cell subsets
Administration General Services
The administrative platform is led by the General Secretary with the assistance of the financial management. Its mission is the management of human resources, finance and movable heritage. It also coordinates the general kitchen and washroom services, prevention & safety, technology transfer and development, informatics.
Notice: Undefined variable: contact_addr in /homepages/40/d483507699/htdocs/location.php on line 21
HRH Princess Caroline of Hanover, who through the Princess Grace Foundation, already supports medical research and anything that helps to relieve the sick children in France and around the world, has agreed to commit to our side so that our Center of Molecular medicine continues to meet the current challenges and fight diseases, and in particular the ones affecting children.